Patent - Page 5
This is FindLaw's collection of Patent articles, part of the Intellectual Property section of the Corporate Counsel Center. Law articles in this archive are predominantly written by lawyers for a professional audience seeking business solutions to legal issues. Start your free research with FindLaw.
Intellectual Property
Patent Articles
-
The Federal Circuit Court of Appeals ruled June 18th that a federal court in a patent dispute was wrong to disregard expert testimony and grant summary judgment upholding two patents. The expert's testimony, which concerned the obviousness of the patented technology, raised a sufficient factual dispute to require a trial as to the validity of the patents, the court said. -
Legislation that would dramatically overhaul U.S. patent law appears to be on a fast track in Congress, with Senators Patrick Leahy (D-Vermont) and Orrin Hatch (R-Utah) leading the charge. But legal and business groups are finding themselves at odds over the legislation, with some saying it would reduce patent litigation costs and improve patent quality while others say it would do just the opposite. -
The four types of intellectual property: copyrights, trademarks, patents, and trade secrets, protect. -
This guide provides small business owners with basic information about patents, trademarks, and copyright. -
Depending on your idea, the best protection my be a patent. -
This article addresses the issue of business method patents and its effect on the e-commerce industry. -
In earlier issues, we have written about the torpedoing of Seiko-Epson's submarine patents and the sinking of Cano. -
The patent law specifies the general field of subject matter that can be patented and the conditions under which a patent may be obtained. -
Prior to the passage of the Bayh-Dole Act (the "Act") by Congress in 1980, inventions, writings and creations of American academic institutions were for the most part freely contributed to the body of public knowledge. -
On December 5, 2002, the Supreme Court of Canada in a five-four decision held, in Harvard College v. Canada (Commissioner of Patents), that higher life forms (in this case, a transgenic mouse) cannot be patented. This is an important decision, and should be reflected upon even if you are not in biotech/life sciences. Next month I will look closely at this decision, and its potential ramifications.